Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.

Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL; REACH Registry Investigators.

Eur Heart J. 2014 Nov 1;35(41):2864-72. doi: 10.1093/eurheartj/ehu080. Epub 2014 Feb 28.

2.

Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.

Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, Yeo KK, Anderson D, Amsterdam EA, Laird JR.

J Am Heart Assoc. 2014 Apr 10;3(2):e000697. doi: 10.1161/JAHA.113.000697.

3.

Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia.

Westin GG, Armstrong EJ, Bang H, Yeo KK, Anderson D, Dawson DL, Pevec WC, Amsterdam EA, Laird JR.

J Am Coll Cardiol. 2014 Feb 25;63(7):682-90. doi: 10.1016/j.jacc.2013.09.073. Epub 2013 Dec 4.

4.

Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival.

Suckow BD, Kraiss LW, Schanzer A, Stone DH, Kalish J, DeMartino RR, Cronenwett JL, Goodney PP; Vascular Study Group of New England.

J Vasc Surg. 2015 Jan;61(1):126-33. doi: 10.1016/j.jvs.2014.05.093. Epub 2014 Jul 16.

5.

Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).

Kiesz RS, Wiernek SL, Wiernek BK, Radvany MG, Buszman PP, Szymanski R, Konkolewska MD, Martin JL, Buszman PE.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E244-50. doi: 10.1002/ccd.24756. Epub 2013 Mar 9.

PMID:
23172729
6.

Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.

Zeymer U, Parhofer KG, Pittrow D, Binz C, Schwertfeger M, Limbourg T, Röther J.

Clin Res Cardiol. 2009 Apr;98(4):249-56. doi: 10.1007/s00392-009-0754-1. Epub 2009 Feb 16.

PMID:
19221687
7.

Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.

Tomoi Y, Soga Y, Iida O, Hirano K, Suzuki K, Kawasaki D, Yamauchi Y, Miyashita Y, Tazaki J, Nobuyoshi M.

Cardiovasc Interv Ther. 2013 Oct;28(4):374-82. doi: 10.1007/s12928-013-0188-6. Epub 2013 Jun 12.

PMID:
23756936
8.

Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.

9.

The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions.

Ardati AK, Kaufman SR, Aronow HD, Nypaver TJ, Bove PG, Gurm HS, Grossman PM.

Circ Cardiovasc Interv. 2012 Dec;5(6):850-5. doi: 10.1161/CIRCINTERVENTIONS.112.975862. Epub 2012 Dec 11.

10.

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection.

Tazaki J, Morimoto T, Sakata R, Okabayashi H, Yamazaki F, Nishiwaki N, Mitsudo K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

J Vasc Surg. 2014 Sep;60(3):604-12.e2. doi: 10.1016/j.jvs.2014.03.280. Epub 2014 May 3.

PMID:
24797553
11.

Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).

Natsuaki M, Furukawa Y, Morimoto T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2012 Dec 1;110(11):1568-77. doi: 10.1016/j.amjcard.2012.07.021. Epub 2012 Aug 28.

PMID:
22935527
12.

Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.

Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

Circ J. 2012;76(6):1369-79. Epub 2012 Mar 15.

13.

Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.

Abola MT, Bhatt DL, Duval S, Cacoub PP, Baumgartner I, Keo H, Creager MA, Brennan DM, Steg PG, Hirsch AT; REACH Investigators.

Atherosclerosis. 2012 Apr;221(2):527-35. doi: 10.1016/j.atherosclerosis.2012.01.002. Epub 2012 Jan 24.

PMID:
22321872
14.

Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥ 80 years of age: observations from the CREDO-Kyoto Registry Cohort-2.

Natsuaki M, Morimoto T, Furukawa Y, Shiomi H, Ono K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Atherosclerosis. 2014 Dec;237(2):821-8. doi: 10.1016/j.atherosclerosis.2014.10.108. Epub 2014 Nov 4.

PMID:
25463128
15.

Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease.

Armstrong EJ, Anderson DR, Yeo KK, Singh GD, Bang H, Amsterdam EA, Freischlag JA, Laird JR.

J Vasc Surg. 2015 Jul;62(1):157-165.e1. doi: 10.1016/j.jvs.2015.01.051. Epub 2015 Apr 8.

PMID:
25864042
16.

Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis.

Antoniou GA, Fisher RK, Georgiadis GS, Antoniou SA, Torella F.

Vascul Pharmacol. 2014 Nov;63(2):79-87. doi: 10.1016/j.vph.2014.09.001. Epub 2014 Oct 18. Review.

PMID:
25446168
17.
18.

Very long-term outcome of peripheral arterial disease in patients undergoing percutaneous coronary revascularization: a retrospective analysis.

Pullara A, D'Ascenzo F, Gonella A, Moretti C, Sciuto F, Omedè PL, Bollati M, Biondi Zoccai G, Gaita F, Sheiban I.

Minerva Cardioangiol. 2012 Dec;60(6):553-60.

PMID:
23147433
19.

Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry.

Furukawa Y, Taniguchi R, Ehara N, Ozasa N, Haruna Y, Saito N, Doi T, Hoshino K, Shizuta S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators.

Circ J. 2008 Dec;72(12):1937-45. Epub 2008 Oct 24.

20.

High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.

Stoekenbroek RM, Boekholdt SM, Fayyad R, Laskey R, Tikkanen MJ, Pedersen TR, Hovingh GK; Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group.

Heart. 2015 Mar;101(5):356-62. doi: 10.1136/heartjnl-2014-306906. Epub 2015 Jan 16.

PMID:
25595417
Items per page

Supplemental Content

Write to the Help Desk